1386401-70-2 Usage
Uses
Used in Pharmaceutical Research:
4-[3-(2-methanesulfinyl-pyrimidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino]-cyclohexyl-carbamic acid tert-butyl ester is used as a research compound for exploring its potential in pharmaceutical development due to its unique molecular structure and functional groups.
Used in Drug Development:
In the Drug Development industry, 4-[3-(2-methanesulfinyl-pyrimidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino]-cyclohexyl-carbamic acid tert-butyl ester is used as a candidate molecule for the development of new drugs, given its complex structure and potential for interaction with biological targets.
Used in Chemical Synthesis:
4-[3-(2-methanesulfinyl-pyrimidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylamino]-cyclohexyl-carbamic acid tert-butyl ester is used as a synthetic intermediate for the creation of other complex organic molecules, leveraging its versatile structure and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 1386401-70-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,6,4,0 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1386401-70:
(9*1)+(8*3)+(7*8)+(6*6)+(5*4)+(4*0)+(3*1)+(2*7)+(1*0)=162
162 % 10 = 2
So 1386401-70-2 is a valid CAS Registry Number.
1386401-70-2Relevant academic research and scientific papers
PYRAZOLO PYRIMIDINES AS DYRK1A AND DYRK1B INHIBITORS
-
Page/Page column 37-38, (2012/08/07)
Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.
